Excipient: Super Refined™ Polysorbate 80
Product Description
Croda pharma
-
Country/Region:United Kingdom
-
On CPHI since:2015
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
.jpg)
Categories
Specifications
Croda pharma
-
Country/Region:United Kingdom
-
On CPHI since:2015
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
More Products from Croda pharma (26)
-
Product Adjuvant Systems for Vaccines
We enable next-generation vaccine development through a diverse portfolio of world-leading vaccine adjuvants, immunomodulators and adjuvant formulations.
We passionately develop new adjuvant technologies and partner to develop the vaccines of tomorrow.
Our extensive expertise in immunology and fo... -
Product Bioprocessing solutions and excipients for protein therapeutic formulations
From excipients for protein therapeutic formulations, to innovating solutions for bioprocessing, we have decades of experience in protein delivery. TALK TO US about our latest launches: Virodex™ detergent range, a sustainable alternative to Triton™ X-100 for viral inactivation and cell lysis. Plus, Tween... -
Product Excipients for Consumer Health
Croda Pharma's Consumer Health offering combines our technical expertise with regulatory knowledge to help our customers market innovative products with consumer relevant claims, alongside supporting formulation development challenges within the Consumer Health market.
Our excipient solutions support ... -
Product High purity excipients for small molecule delivery
We offer high purity, multi-compendial, pharmaceutical excipients for small molecule drug delivery. Our portfolio of high purity excipient products and speciality chemistries solve formulation challenges and enhance drug delivery across a variety of administration routes and dosage forms. We are market le... -
Product Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics
Avanti Polar Lipids, part of Croda Pharma, develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
We develop and manufacture highly specialised lipids used in Lipid Nanoparticle (LNP) deliv... -
Product Excipient: Super Refined™ PEG 400
Super Refined PEGs are solvents for use with the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes polar impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, reducing excipi... -
Product Excipient: Super Refined™ Polysorbate 20
Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to red... -
Product Vaccine Adjuvant: Alhydrogel™
• Alhydrogel is a range of aluminium hydroxide gel products which have been specifically developed for use as an adjuvant in human and veterinary vaccines • The gel is a suspension of boehmite-like (aluminium oxyhydroxide) hydrated nano/micron size crystals in loose aggregates • The products have v... -
Product Excipient: Super Refined™ DEGEE
Super Refined DEGEE is ideal for use in topical and transdermal applications to enhance the permeation of poorly water-soluble API’s through various layers of the skin, thereby improving drug delivery. It can also be used as a co-solvent in self-emulsifying drug delivery systems (SEDDS), or self-microe... -
Product Excipient: Super Refined™ P35 Caster Oil
Super Refined P35 Castor Oil is a castor oil derivative, resulting from the reaction of glycerol ricinoleate and 35 mols of ethylene oxide. This product is a liquid nonionic solubiliser and emulsifier, characteristic of a slightly yellow hue, and is intended for use in parenteral, ophthalmic, oral, and... -
Product Vaccine Adjuvant: Quil-A™
• Quil-A is a highly purified and concentrated saponin adjuvant purified from bark extract of the Quillaja saponaria Molina tree which has been specifically developed for use as an adjuvant in vaccines • Quil-A saponin was originally purified and characterised by Dr. Pharm • Kristian Dalsgaard in 1... -
Product Cholesterol
W/O emulsifier, emulsion stabiliser and moisturiser with skin conditioning and barrier repair benefits. High purity grade also available. Recommended topical usage levels of 0.5-5%. Cholesterol in the free and combined state is the most widely occurring sterol in animal tissue. It is an essential compound ...
Croda pharma resources (16)
-
News Two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. -
Brochure Addressing the challenges of vaccine formulation
To this day, our focus has been to successfully develop, manufacture and market high-quality adjuvants for our pharmaceutical customers. This heritage makes our vaccine adjuvants unique in the industry. A heritage we are proud of.
Our industry-leading, Alhydrogel®, Adju-Phos® and Quil-A® are widely recognised in the vaccine industry for their unmatched track record when it comes to a proven history of safe and effective use. -
Sponsored Content Croda: Solutions for Your High Value Drug Products
Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs are prone to degradation when exposed to various chemical species.
-
Brochure Avanti cGMP Manufactured Lipids
For over 40 years Avanti has provided API (Active Pharmaceutical Ingredient) Technology Development for Pharmaceutical and Biotechnology companies. Our unique reputation for quality in the development of pre-clinical and clinical candidates is well established. Our full range of services include process chemistry, scale-up manufacturing, supply chain management with analytical and regulatory requirements. Avanti’s experienced staff of chemists and lipid analysts are ready to meet your development needs with pre-clinical through phase III and commercial launch. -
Sponsored Content Avanti & Croda-Denmark: Advancing Vaccine Adjuvant Research
Adjuvants. You’ve seen them on our website. You’ve seen them featured in our blog articles. Now we want to show you how Avanti’ & Croda-Denmark can enhance your vaccine adjuvant research!
Keep reading to learn more!
-
Brochure Croda Mill Hall press release
Croda International Plc, the company that uses smart science to create high performance ingredients and technologies that improve lives, is excited to announce the expansion of its Mill Hall high purity excipients facility. This investment confirms Croda’s commitment to building its Life Sciences business and developing innovative pharmaceutical excipients, reinforcing Croda’s Purpose to use Smart science to improve lives™. With this latest Mill Hall expansion, Croda continues their ambitious target to become People Positive by 2030 by contributing to the successful development of 25% of WHO-listed pipeline vaccines.
To find out more, please visit: https://www.croda.com/en-gb/news/2021/08/croda-expands-its-high-purity-pharmaceutical-excipients-manufacturing-capability -
Video Supporting the World's Biggest Challenges
Smart Science to Improve Lives. For more than 75 years Croda Denmark has been dedicated to safe and effective adjuvants for use in both human and veterinary vaccines, as well as blood fractioning processes. We offer an experienced passionate team and personal interaction with comprehensive on-site advice and support anywhere in the world. -
Brochure Croda’s response to Sustainable Markets Initiative for supplier sustainability
We are pleased to provide the following overview of Croda’s current status regarding the relevant supplier targets announced. -
Brochure Sustainably sourced squalene: the alternative to shark derived squalene
Produced using cutting-edge technology that centres on synthetic biology, our pharmaceutical-grade squalene has superior purity, naturally setting it apart. -
Brochure Free whitepaper: Vaccines for a more sustainable future
Find out what steps you can take to help ensure that everyone gets the vaccines they need. -
Brochure Virodex™ detergents: Superior replacements to Triton™ X-100
REACH-compliant, compendial, sustainable, optimised for use in biomanufacturing of recombinant proteins, blood fractionation products, viral vectors and more! -
Brochure Launching... natural phospholipids!
We are specialised in the extraction and purification of phospholipids for pharmaceutical and nutraceutical applications. -
Industry Webinar Formulation solutions for cannabinoids
The use of cannabinoids (CBD) is a growing marketplace dominated by oral and topical formulations. Croda offers Super Refined™ formulation solutions providing benefits such as; improving stability and reducing taste impact. Find out more here: -
Datasheet Polysorbates for Biopharma
Super Refined™ Polysorbates for Biopharma applications.
This document is relevant to the following market areas
Health Care - DermaHealth Care - Pharma
Health Care - Nutra
Health Care - Animal Health
This document is attached to the following products
Super Refined™ Polysorbate 80 -
Datasheet Pharmaceutical excipients for ophthalmic formulations
Pharmaceutical excipients for ophthalmic formulations.
This document is relevant to the following market areas
Health Care - Derma
Health Care - Pharma
Health Care - Nutra
Health Care - Animal Health -
Datasheet Super Refined™ pharmaceutical excipients
Super Refined™ pharmaceutical excipients.